LUNGevity is a well-established thought leader in lung cancer legislative and regulatory policy, particularly around issues that affect advancement of innovation and access to care. We leverage our internal research, as well as collaborations with experts in lung cancer, to inform our policy work.
We participate in a variety of committees, working groups, and advisory boards to represent the interests and perspectives of people with lung cancer. We present at Capitol Hill briefings; submit letters to legislators, regulators, and independent organizations seeking patient input; and convene multi-stakeholder meetings to resolve complex issues that hinder patients’ access to diagnostics and the most advanced therapeutics.
Through our policy work, we are making positive strides in breaking down barriers to patients’ access to high-quality care and treatment innovation. This work includes:
- Advocating for lung cancer research funding
- Conducting research to uncover gaps and barriers that can be addressed through policy reforms
- Working to ensure precision medicine is accessible to people with lung cancer
- Promoting policies that guarantee fair and equitable access to lung cancer care
- Removing barriers to lung cancer screening and increasing access to early detection methods
- Ensuring that clinical trials are conducted in a safe and efficient manner to support rapid delivery of new therapies to patients
- Activating advocates in the community through the LUNGevity Action Network, which empowers people looking to make a difference with the information and tools they need to take action. You can have a part in our policy and outreach efforts by joining the LUNGevity Action Network!